Sign in

CIK 0001851484 · <br>Emerging growth company

CITIUS ONCOLOGY, INC.

Sign in to watch
Ticker
CTOR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Sep 30
Incorporated
DE
Entity type
operating
EIN
994362660
Phone
(908) 967-6677
Business address
11 COMMERCE DRIVE, 1ST FLOOR, CRANFORD, NJ, 07016
Former names
TenX Keane Acquisition
  1. 4 Derivatives Options or other derivatives
  2. 3 Insider Initial Statement of Ownership
  3. 3 Insider Initial Statement of Ownership
  4. 3 Insider Initial Statement of Ownership
  5. 3 Insider Initial Statement of Ownership
  6. 3 Insider Initial Statement of Ownership
  7. 3 Insider Initial Statement of Ownership
  8. 3 Insider Initial Statement of Ownership
  9. 3 Insider Initial Statement of Ownership
  10. 3 Insider Initial Statement of Ownership
  11. 25-NSE Other Notification of Removal from Listing
  12. 10-Q Report Quarterly Report
  13. 8-K Event Executive or director change · Shareholder vote results · Other events
  14. 425 Deal Prospectus/Communication re Business Combination
  15. 8-K Event Material agreement · New debt or obligation
  16. SEC STAFF LETTER Other SEC Staff Letter Redacted Exhibit
  17. EFFECT Other Notice of Effectiveness
  18. 424B3 Offering Prospectus
  19. CORRESP Other Correspondence Between Filers and SEC Staff
  20. S-4/A Deal Registration Statement - Business Combination

Page 9 of 14 · 268 filings